July's Top Rx Brands by TV Ad Spend
Skyrizi leads for the second month in a row, spending an estimated $23.2 million on national TV ads.
According to iSpot data recently shared with FiercePharma, Skyrizi leads the list of Rx brands that spent the most on national TV ads in July. The immunology drug from AbbVie had an estimated outlay of $23.2 million, a decrease from its June spend of $26.6 million.
Some additional insights about the pharma brands that spent the most in July:
- In total, the top ten brands spent an estimated $126.3 million, notably lower than what the top ten brands spent in June ($163.2 million).
- Dupixent rises from No. 3 in June to No. 2 in July, with an estimated outlay of $20 million on 10 spots, a slight decrease from the brand's June spend of $21.4 million.
- Month-over-month ranking newcomers include Vraylar (No. 5, $10.6 million in estimated spend), Farxiga (No. 7, $8.8 million) and Ocrevus (No. 9, $7.6 million).
